Holen Sie sich die Stockscreener-App
0.6748
2.83%
0.0186
Handel nachbörslich:
.67
-0.0048
-0.71%
Humacyte Inc Aktie (HUMA) Neueste Nachrichten
Humacyte, Inc. (HUMA) Suffers a Larger Drop Than the General Market: Key Insights - Yahoo Finance
Enterprise value to EBIT forward of Humacyte, Inc. – NASDAQ:HUMAW - TradingView
Investor Notice: Robbins LLP Informs Stockholders of the Class A - GuruFocus
Humacyte, Inc. (HUMA) beats stock market upswing: What investors need to know - MSN
Humacyte, Inc. (HUMA) Beats Stock Market Upswing: What Investors Need to Know - Yahoo Finance
Humacyte appoints two nephrologists as commercial advisors By Investing.com - Investing.com South Africa
Humacyte appoints two nephrologists as commercial advisors - Investing.com
Humacyte Appoints Key Nephrologists as Advisors to Prepare for Planned Commercialization of the ATEV in Dialysis Access - The Manila Times
Form 13D/A HUMACYTE For: 13 July By Investing.com - Investing.com Nigeria
Fresenius to sell 5M Humacyte (HUMA) shares under Rule 10b5-1 plan - Stock Titan
Humacyte Inc (HUMA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Humacyte, Inc. (HUMA) stock sinks as market gains: Here's why - MSN
Humacyte, Inc. (HUMA) Stock Declines While Market Improves: Some Information for Investors - MSN
HUMAHumacyte Inc Options - Finviz
HUMA Should I Buy - Intellectia AI
HUMA Investors Have Opportunity to Lead Humacyte, Inc. Securitie - GuruFocus
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Enterprise value to revenue forward of Humacyte, Inc. – NASDAQ:HUMAW - TradingView
Humacyte, Inc. Warrant 2021-27.08.26 on Humacyte Financial Disclosures & SEC Filings - TradingView
Humacyte, Inc. (HUMA) Stock Sinks As Market Gains: Here's Why - Yahoo Finance
Humacyte Announces $50 Million Public Offering of Common Stock - Global Legal Chronicle
HUMA stock plunges after-hours on proposed share offering even as dialysis data impresses - MSN
Here's Why Humacyte, Inc. (HUMA) Fell More Than Broader Market - MSN
Enterprise value to revenue forward of Humacyte, Inc. – NASDAQ:HUMA - TradingView
Price to earnings forward of Humacyte, Inc. – NASDAQ:HUMA - TradingView
Humacyte (HUMA) Stock Fair Value Falls As Split Analyst Views Follow V012 Data - Yahoo Finance
Price to earnings forward of Humacyte, Inc. – BOATS:HUMA - TradingView
Humacyte, Inc. (HUMA) latest stock news and headlines - Yahoo Finance Singapore
Price to book forward of Humacyte, Inc. – BOATS:HUMA - TradingView
Price to sales forward of Humacyte, Inc. – BOATS:HUMA - TradingView
Enterprise value to revenue forward of Humacyte, Inc. – BOATS:HUMA - TradingView
Humacyte, Inc. Actuals & Estimates (NASDAQ:HUMA) - TradingView
Enterprise value to EBITDA forward of Humacyte, Inc. – BOATS:HUMA - TradingView
Enterprise value to EBIT forward of Humacyte, Inc. – BOATS:HUMA - TradingView
HUMA Forecast — Price Target — Prediction for 2027 - TradingView
Humacyte Inc (HUMA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
BTIG Maintains Humacyte(HUMA.US) With Buy Rating, Cuts Target Price to $2 - Moomoo
Form 13G Humacyte For: 22 June By Investing.com - Investing.com South Africa
Davidson Kempner reports 4.74% stake in Humacyte (NASDAQ: HUMA) - Stock Titan
Brokers Suggest Investing in Humacyte, Inc. (HUMA): Read This Before Placing a Bet - Yahoo Finance
Humacyte, Inc. (HUMA) dips more than broader market: What you should know - MSN
Piper Sandler Maintains Humacyte(HUMA.US) With Hold Rating, Maintains Target Price $1 - Moomoo
Humacyte Inc (HUMAW) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Analysts Offer Insights on Healthcare Companies: Humacyte (HUMA) and Qiagen (QGEN) - The Globe and Mail
Humacyte Inc (HUMAW) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Humacyte Inc (HUMA) Institutional Confidence - TradingKey
Humacyte Inc (HUMA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Humacyte Inc (HUMA) Valuation: PE, PB & Fair Value Analysis - TradingKey
Humacyte Inc (HUMA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Humacyte Inc (HUMAW) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Humacyte Inc (HUMAW) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Humacyte Inc (HUMAW) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Humacyte Inc (HUMAW) Valuation: PE, PB & Fair Value Analysis - TradingKey
Humacyte Inc (HUMAW) Institutional Confidence - TradingKey
Humacyte Inc (HUMAW) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Humacyte Inc (HUMA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
1.89%
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):